Offerings

The offerings supplied by CIS Life Sciences focus on the competition and other organizations providing key inputs into the clients'/competitors' growth strategy. They include:

1. Current/Completed Clinical Trials
2. Delivery Device Development
3. Due Diligence (M&A, Licensing, Partners)
4. Early launch marketing tools and channels
5. Generic Strategies
6. Health Outcomes/Pharmacogenomics
7. Lifecycle Strategies
8. Manufacturing Analysis
9. Market Opportunity Analysis
10. Marketing Strategies-pre/early/post-launch phases
11. Patent Infringement/Detection
12. Planned Clinical Trials
13. Portfolio Strategy by Disease Area
14. Regional/Global sales model analysis
15. Regulatory Strategies
16. Strategic Profiling

Please click here to see when, during a drugs lifecycle, CIS Life Sciences is typically engaged by the client to conduct the above offerings.